Q5VT52 (RPRD2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 82.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Regulation of nuclear pre-mRNA domain-containing protein 2 | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1461 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Subunit structure | Associates with the RNA polymerase II complex. Ref.17 |
| Sequence similarities | Contains 1 CID domain. |
| Sequence caution | The sequence AAF28922.1 differs from that shown. Reason: Erroneous initiation. The sequence AAH45623.2 differs from that shown. Reason: Erroneous initiation. |
Ontologies
| Keywords | |
|---|---|
| Coding sequence diversity | Alternative splicing Polymorphism |
| PTM | Phosphoprotein |
| Technical term | 3D-structure Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Cellular_component | DNA-directed RNA polymerase II, holoenzyme Inferred from direct assay Ref.17. Source: UniProtKB |
| Complete GO annotation... | |
Alternative products
| This entry describes 4 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q5VT52-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q5VT52-2) The sequence of this isoform differs from the canonical sequence as follows: 1-37: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 3 (identifier: Q5VT52-3) The sequence of this isoform differs from the canonical sequence as follows: 146-171: Missing. | ||||||
| Isoform 4 (identifier: Q5VT52-4) The sequence of this isoform differs from the canonical sequence as follows: 147-152: TTFKTQ → KCLFLS 153-1461: Missing. | ||||||
| Note: Gene prediction based on EST data. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1461 | 1461 | Regulation of nuclear pre-mRNA domain-containing protein 2 | PRO_0000244355 | ||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||
| Domain | 19 – 149 | 131 | CID | |||||||||||||||||||||||||
| Compositional bias | 4 – 19 | 16 | Gly/Ser-rich | |||||||||||||||||||||||||
| Compositional bias | 457 – 950 | 494 | Ser-rich | |||||||||||||||||||||||||
| Compositional bias | 1054 – 1057 | 4 | Poly-Gln | |||||||||||||||||||||||||
| Compositional bias | 1152 – 1158 | 7 | Poly-Gly | |||||||||||||||||||||||||
| Compositional bias | 1195 – 1459 | 265 | Pro-rich | |||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||
| Modified residue | 356 | 1 | Phosphoserine Ref.16 | |||||||||||||||||||||||||
| Modified residue | 358 | 1 | Phosphothreonine Ref.16 | |||||||||||||||||||||||||
| Modified residue | 374 | 1 | Phosphoserine Ref.9 Ref.11 Ref.12 Ref.13 Ref.14 Ref.16 | |||||||||||||||||||||||||
| Modified residue | 473 | 1 | Phosphoserine Ref.13 Ref.14 | |||||||||||||||||||||||||
| Modified residue | 476 | 1 | Phosphoserine Ref.13 | |||||||||||||||||||||||||
| Modified residue | 479 | 1 | Phosphoserine Ref.12 | |||||||||||||||||||||||||
| Modified residue | 482 | 1 | Phosphothreonine Ref.13 Ref.14 | |||||||||||||||||||||||||
| Modified residue | 485 | 1 | Phosphoserine Ref.12 Ref.13 | |||||||||||||||||||||||||
| Modified residue | 517 | 1 | Phosphothreonine Ref.12 Ref.14 | |||||||||||||||||||||||||
| Modified residue | 593 | 1 | Phosphoserine Ref.12 Ref.13 Ref.14 Ref.16 | |||||||||||||||||||||||||
| Modified residue | 598 | 1 | Phosphothreonine Ref.13 | |||||||||||||||||||||||||
| Modified residue | 614 | 1 | Phosphoserine Ref.10 Ref.12 Ref.13 Ref.14 | |||||||||||||||||||||||||
| Modified residue | 665 | 1 | Phosphoserine Ref.13 | |||||||||||||||||||||||||
| Modified residue | 723 | 1 | Phosphothreonine Ref.9 Ref.12 Ref.14 | |||||||||||||||||||||||||
| Modified residue | 730 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||
| Modified residue | 732 | 1 | Phosphothreonine Ref.13 | |||||||||||||||||||||||||
| Modified residue | 758 | 1 | Phosphoserine Ref.10 Ref.12 | |||||||||||||||||||||||||
| Modified residue | 762 | 1 | Phosphoserine Ref.10 | |||||||||||||||||||||||||
| Modified residue | 826 | 1 | Phosphoserine Ref.13 | |||||||||||||||||||||||||
| Modified residue | 900 | 1 | Phosphoserine Ref.12 | |||||||||||||||||||||||||
| Modified residue | 909 | 1 | Phosphoserine Ref.12 Ref.13 | |||||||||||||||||||||||||
| Modified residue | 928 | 1 | Phosphoserine Ref.12 Ref.14 | |||||||||||||||||||||||||
| Modified residue | 1021 | 1 | Phosphoserine By similarity | |||||||||||||||||||||||||
| Modified residue | 1099 | 1 | Phosphoserine Ref.9 Ref.12 Ref.13 Ref.14 | |||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||
| Alternative sequence | 1 – 37 | 37 | Missing in isoform 2. | VSP_019546 | ||||||||||||||||||||||||
| Alternative sequence | 146 – 171 | 26 | Missing in isoform 3. | VSP_019547 | ||||||||||||||||||||||||
| Alternative sequence | 147 – 152 | 6 | TTFKTQ → KCLFLS in isoform 4. | VSP_035574 | ||||||||||||||||||||||||
| Alternative sequence | 153 – 1461 | 1309 | Missing in isoform 4. | VSP_035575 | ||||||||||||||||||||||||
| Natural variant | 351 | 1 | M → V. Corresponds to variant rs41273537 [ dbSNP | Ensembl ]. | VAR_061700 | ||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||
| Sequence conflict | 167 | 1 | W → C in AAF28922. Ref.6 | |||||||||||||||||||||||||
| Sequence conflict | 174 | 1 | T → A in BAG51793. Ref.1 | |||||||||||||||||||||||||
| Sequence conflict | 1297 | 1 | P → L in BAG51793. Ref.1 | |||||||||||||||||||||||||
| Sequence conflict | 1385 | 1 | G → R in BAG51793. Ref.1 | |||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||
| Helix | 20 – 33 | 14 | ||||||||||||||||||||||||||
| Helix | 38 – 50 | 13 | ||||||||||||||||||||||||||
| Helix | 52 – 54 | 3 | ||||||||||||||||||||||||||
| Helix | 55 – 68 | 14 | ||||||||||||||||||||||||||
| Helix | 71 – 87 | 17 | ||||||||||||||||||||||||||
| Turn | 88 – 92 | 5 | ||||||||||||||||||||||||||
| Helix | 95 – 101 | 7 | ||||||||||||||||||||||||||
| Helix | 104 – 109 | 6 | ||||||||||||||||||||||||||
| Turn | 114 – 116 | 3 | ||||||||||||||||||||||||||
| Helix | 117 – 130 | 14 | ||||||||||||||||||||||||||
| Helix | 135 – 144 | 10 | ||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Placenta. |
| [2] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Salivary gland. |
| [3] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). Tissue: Testis. |
| [6] | "Human partial CDS cloned from CD34+ stem cells." Zhang Q.H., Ye M., Zhou J., Shen Y., Wu X.Y., Guan Z.Q., Wang L., Fan H.Y., Mao Y.F., Dai M., Huang Q.H., Chen S.J., Chen Z. Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-167 (ISOFORM 1). Tissue: Umbilical cord blood. |
| [7] | "Characterization of cDNA clones in size-fractionated cDNA libraries from human brain." Seki N., Ohira M., Nagase T., Ishikawa K., Miyajima N., Nakajima D., Nomura N., Ohara O. DNA Res. 4:345-349(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 10-1461 (ISOFORM 1). Tissue: Brain. |
| [8] | "Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones." Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T. DNA Res. 9:99-106(2002) [PubMed] [Europe PMC] [Abstract] Cited for: SEQUENCE REVISION. |
| [9] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-374; THR-723 AND SER-1099, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [10] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-614; SER-758 AND SER-762, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [11] | "Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment." Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J. J. Proteome Res. 7:5167-5176(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-374, MASS SPECTROMETRY. Tissue: T-cell. |
| [12] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-374; SER-479; SER-485; THR-517; SER-593; SER-614; THR-723; SER-758; SER-900; SER-909; SER-928 AND SER-1099, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [13] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-374; SER-473; SER-476; THR-482; SER-485; SER-593; THR-598; SER-614; SER-665; THR-732; SER-826; SER-909 AND SER-1099, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [14] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-374; SER-473; THR-482; THR-517; SER-593; SER-614; THR-723; SER-928 AND SER-1099, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [15] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [16] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356; THR-358; SER-374 AND SER-593, MASS SPECTROMETRY. |
| [17] | "Control of the RNA polymerase II phosphorylation state in promoter regions by CTD interaction domain-containing proteins RPRD1A and RPRD1B." Ni Z., Olsen J.B., Guo X., Zhong G., Ruan E.D., Marcon E., Young P., Guo H., Li J., Moffat J., Emili A., Greenblatt J.F. Transcription 2:237-242(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION IN THE RNA POLYMERASE II COMPLEX. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AK056707 mRNA. Translation: BAG51793.1. AK291703 mRNA. Translation: BAF84392.1. BX641025 mRNA. Translation: CAE46016.1. AL356356, AL611942, BX284695 Genomic DNA. Translation: CAI15496.1. AL356356, AL611942, BX284695 Genomic DNA. Translation: CAI15497.1. AL611942, AL356356, BX284695 Genomic DNA. Translation: CAH70313.1. AL611942, AL356356, BX284695 Genomic DNA. Translation: CAH70314.1. AL611942 Genomic DNA. Translation: CAH70315.1. BX284695, AL356356, AL611942 Genomic DNA. Translation: CAI17373.1. BX284695, AL356356, AL611942 Genomic DNA. Translation: CAI17374.1. CH471121 Genomic DNA. Translation: EAW53552.1. BC045623 mRNA. Translation: AAH45623.2. Different initiation. AF161362 mRNA. Translation: AAF28922.1. Different initiation. AB007929 mRNA. Translation: BAA32305.2. | ||||||||||||
| IPI | IPI00384541. IPI00639879. IPI00647267. IPI00760919. | ||||||||||||
| PIR | T00074. | ||||||||||||
| RefSeq | NP_056018.2. NM_015203.3. | ||||||||||||
| UniGene | Hs.213666. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q5VT52. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | Q5VT52. 4 interactions. | ||||||||||||
| MINT | MINT-1603162. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q5VT52. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 74746888. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q5VT52. | ||||||||||||
| PRIDE | Q5VT52. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 23248. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000369067; ENSP00000358063; ENSG00000163125. ENST00000369068; ENSP00000358064; ENSG00000163125. ENST00000401000; ENSP00000383785; ENSG00000163125. ENST00000579067; ENSP00000462536; ENSG00000266562. ENST00000584319; ENSP00000464492; ENSG00000266562. ENST00000584841; ENSP00000463897; ENSG00000266562. | ||||||||||||
| GeneID | 23248. | ||||||||||||
| KEGG | hsa:23248. | ||||||||||||
| UCSC | uc001eup.4. human. uc009wlr.3. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 23248. | ||||||||||||
| GeneCards | GC01P150335. | ||||||||||||
| H-InvDB | HIX0019981. | ||||||||||||
| HGNC | HGNC:29039. RPRD2. | ||||||||||||
| HPA | HPA045778. | ||||||||||||
| MIM | 614695. gene. | ||||||||||||
| neXtProt | NX_Q5VT52. | ||||||||||||
| PharmGKB | PA162402062. | ||||||||||||
| HUGE | Search... | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | NOG331230. | ||||||||||||
| HOVERGEN | HBG104176. | ||||||||||||
| InParanoid | Q5VT52. | ||||||||||||
| OMA | GKGNRGH. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q5VT52. | ||||||||||||
| Bgee | Q5VT52. | ||||||||||||
| CleanEx | HS_RPRD2. | ||||||||||||
| Genevestigator | Q5VT52. | ||||||||||||
| GermOnline | ENSG00000163125. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 1.25.40.90. 1 hit. | ||||||||||||
| InterPro | IPR006569. CID_dom. IPR008942. ENTH_VHS. IPR006903. RNA_pol_II-bd. [Graphical view] | ||||||||||||
| Pfam | PF04818. CTD_bind. 1 hit. [Graphical view] | ||||||||||||
| SMART | SM00582. RPR. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF48464. ENTH_VHS. 1 hit. | ||||||||||||
| PROSITE | PS51391. CID. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| ChiTaRS | RPRD2. human. | ||||||||||||
| GenomeRNAi | 23248. | ||||||||||||
| NextBio | 44942. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | RPRD2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q5VT52 Secondary accession number(s): A8K6N8 Q9P0D7 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
